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TO THE EDITOR
Chronic itch has been associated
with increased levels of epidermal
nerve growth factor (NGF) and
enhanced neuronal signaling, for ins-
tance in atopic dermatitis (AD) patients
(Tominaga et al., 2009; Yamaguchi
et al., 2009). Experimentally, pruritus
can be elicited in AD independent of
histamine (Ikoma et al., 2004). Spicules
from Mucuna pruriens (cowhage) also
produce sensations of itch when inser-
ted into the epidermis of humans
(Namer et al., 2008; Sikand et al.,
2009). Cowhage activates mechano-
responsive ‘‘polymodal’’ C-nociceptors
in humans and also Ad fibers in monkey
(Ringkamp et al., 2011) and evokes itch
sensations at an intensity comparable to
histamine but without an accompany-
ing axon reflex flare reaction.
Our understanding of nonhistami-
nergic itch has increased tremendously
during the past decade. Increased levels
of NGF mRNA and elevated keratino-
cyte and serum NGF content have both
been linked to itch in animal models
(Takano et al., 2005; Yamaura et al.,
2011). Anti-NGF treatment in these
animals significantly reduced dermatitis
scores, the number of epidermal nerve
fibers, and scratching behavior (Takano
et al., 2005). In AD patients, enhanced
levels of NGF in epidermal and horny
layers correlated with the severity
of itching (Tominaga et al., 2009;
Yamaguchi et al., 2009). We therefore
hypothesized that NGF sensitizes skin
nociceptors in AD patients and there-
by increases pruritus. In healthy
volunteers, intradermally administered
NGF chronically sensitizes nociceptors,
resulting in a localized hyperalgesia
to heat and a prolonged mechanical
hyperalgesia (Rukwied et al., 2010;
Obreja et al., 2011). It is unclear
whether such NGF-mediated nocicep-
tor sensitization also modulates the
sensitivity to various pruritic stimuli.
We therefore injected 1 mg NGF intra-
dermally in healthy male volunteers
(n¼13, age 36±11) and investigated
their itch response to histamine ionto-
phoresis (15mC) and cowhage spicule
insertion (15–20 spicules). Stimuli were
applied at a time point coinciding
with the development of maximum
heat (day 7) and maximum mechanical
hyperalgesia (day 21) determined in a
previous human trial (Rukwied et al.,
2010). Assuming that histamine- and
cowhage-induced itch are mediated by
separate classes of primary afferent
neurons (Johanek et al., 2007; Namer
et al., 2008), our expectation was that
the time course of heat hyper-
algesia would parallel that of increased
histamine sensitivity (mediated by me-
chano-insensitive ‘‘silent’’ nociceptors)
following NGF and similarly that the
time courses of mechanical hyper-
algesia and cowhage-induced itch
(mediated by ‘‘polymodal’’ nocicep-
tors) would be comparable (Namer
et al., 2008).
Maximum histamine-induced itch
within the NGF-treated site did not
differ between day 7 (28±5, visual
analog scale (VAS)) and day 21 (VAS
27±7). VAS area under the curve (AUC)
values calculated during the 10-min
recording period were also similar at
days 7 (492±122) and 21 (489±112).
There were no significant differences bet-
ween histamine-induced itch responses
recorded from treated and untreated
skin (Po0.6, Wilcoxon test, Figure 1a).
Epidermal application of cowhage
spicules at the NGF-treated site on day
7 evoked a peak itch sensation of VAS
25±5 and an AUC of 359±69, both of
which were not significantly different
from values obtained from control skin
(VAS 23±6, AUC 349±73). In contrast,
21 days after NGF treatment, cowhage-
induced itch was significantly enhanced
compared with the control sites, with a
maximum itch of VAS 35±7 (Po0.05,
Wilcoxon test) at day 21 and a corres-
ponding AUC of 522±98 (Po0.02,
Wilcoxon test, Figure 1b).
To differentially quantify ‘‘silent’’
nociceptor sensitization, we also ana-
lyzed the axon reflex flare using laser
Doppler imaging. In comparison with
control skin, NGF did not augment
histamine-induced flare responses at
either day 7 (16±1 vs. 18±2 cm2) or
day 21 (15±2 vs. 16±1 cm2). As in
humans (Johanek et al., 2007), no axon
reflex flare was apparent after appli-
cation of cowhage, neither at the
control nor at the NGF site (flare area
o0.8±0.2 cm2, data not shown).
We further assessed heat pain thresh-
olds and mechanical pain for pressure
(100kPa), pinprick (150mN), and
impact stimuli (8ms–1) (Rukwied et al.,
2010). Heat pain thresholds after NGF
were reduced by 5±0.4 1C at day 7
and 21, but this reduction did not corre-
late with the histamine- or enhanced
cowhage-induced itch (Spearman’s r¼
0.059, P¼ 0.77 (histamine) and r¼
0.023, P¼ 0.91 (cowhage), Figure 2a).
In contrast, pain upon mechanical
stimulation increased after NGF (VAS
from 3±0.8 to 19±4 (pressure), VAS
from 3±1 to 9±3 (pinprick), and
VAS from 5±2 to 21±3 (impact)) and
each of these increases correlated with
cowhage-induced itch sensations (Spear-
man’s r¼ 0.67, Po0.0002 (pressure),
r¼ 0.7, Po0.00001 (pinprick), r¼0.55,
Po0.003 (impact pain, Figure 2b)).
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Our data demonstrate that NGF
sensitizes cowhage- but not histamine-
induced itch. The absence of sensiti-
zation to histamine at a time point
showing the maximum increase in heat
sensitivity is surprising. Apparently,
sensitization of transient receptor
potential (TRPV1) does not necessarily
lead to increased histamine responses,
even though histamine-induced itch is
elevated inside the eczema of AD
(Hosogi et al., 2006) and TRPV1 knock-
out mice showed reduced behavioral
itch responses to histamine (Imamachi
et al., 2009). Thus, central mecha-
nisms may be of greater importance
for histamine-induced itch. The invol-
vement of central components was
demonstrated recently with the injec-
tion of substance P into the dorsal horn
of naked mole rats, leading to altered
nociceptor connectivity in the spinal
cord, thereby determining the presence
or absence of itch behaviour (Smith
et al., 2010).
We found a remarkable sensitization
to cowhage itch at the NGF-treated site,
and the intensity of cowhage-evoked
itch correlated with the level of mecha-
nical hyperalgesia. In humans, cow-
hage activates virtually all mechano-
sensitive ‘‘polymodal’’ units (Namer
et al., 2008) and also some mechano-
sensitive Ad fibers in the monkey
(Ringkamp et al., 2011). Intradermally
administered NGF induces a prominent
sensitization of nociceptors, (Rukwied
et al., 2010) and thus elevated NGF
levels in AD skin (Tominaga et al.,
2009; Yamaguchi et al., 2009) also may
sensitize primary afferents thereby con-
tributing to chronic pruritus. Tests of
cowhage sensitivity and potential anti-
pruritic effects of anti-NGF strategies
in AD patients are crucially required
to assess the clinical relevance of
neuronal sensitization by NGF for their
spontaneous and evoked itch.
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Figure 1. Nerve growth factor (NGF) sensitizes cowhage-, but not histamine-induced itch. Itch sensation
recorded upon (a) histamine iontophoresis and (b) cowhage spicule insertion at day 7 (left panel) and day
21 (right panel) after administration of 1 mg NGF (n¼ 12). In comparison with control skin, cowhage-
induced itch was perceived significantly stronger at the NGF-treated sites at day 21 (marked by asterisks,
Wilcoxon test, Po0.05). Gray bars indicate the time point of histamine iontophoresis and gray cowhage
application. Error bars indicate SEM. VAS, visual analog scale.
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Figure 2. Nerve growth factor (NGF)-induced sensitization of cowhage-induced itch correlates to
mechanical hyperalgesia. Scatterplots of NGF-induced heat hyperalgesia ((a) difference between NGF
and control site ‘‘D heat pain threshold’’) and mechanical hyperalgesia ((b) difference between NGF
and control site ‘‘D impact pain’’ for 8m s–1 stimuli, visual analog scale (VAS) 0–100) correlated to
histamine-induced (left panel, open symbols) and cowhage-induced itch (right panel, closed symbols).
Enhanced cowhage-induced itch after NGF correlated significantly with the NGF-evoked mechanical
hyperalgesia (solid circles, Spearman’s ranking correlation Po0.003). The dotted line indicates the
linear correlation. AUC, area under the curve.
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TO THE EDITOR
Epidermolysis bullosa simplex (EBS),
basal type, is a heterogeneous group
of genetic mechanobullous disorders
characterized by cytolysis of epidermal
basal keratinocytes. In about 75% of the
cases, it is associated with dominantly
inherited mutations in the genes for
keratin 5 (KRT5) or 14 (KRT14) (Bolling
et al., 2010). In rare cases, mutations
in other genes, including PLEC
(NM_000445.3) encoding plectin, DST
(NM_001723.5) encoding BPAG1e, the
isoform 3 of dystonin (UniProt identi-
fier: Q03001-3) (Groves et al., 2010), or
COL17A1 encoding collagen XVII have
been associated with tissue separation
within the basal epidermis (Fine et al.,
2008). Plectin mutations result in dis-
tinct phenotypes, including EBS with
muscular dystrophy, EBS with pyloric
atresia, and EBS-Ogna (Rezniczek
et al., 2010). EBS with muscular dystro-
phy is characterized by congenital
blistering and progressive muscular
weakness, whereas EBS with pyloric
atresia comprises neonatal blistering,
pyloric atresia, and often early demise
(Rezniczek et al., 2010). In contrast to
these severe recessive subtypes, the
dominant EBS-Ogna has a mild course.
It is caused by the specific PLEC
mutation p.Arg2000Trp, and has been
reported in only two families so far
(Koss-Harnes et al., 2002).
Here we report three unrelated
families with EBS-Ogna and describe
eight affected individuals carrying the
PLEC mutation p.Arg2000Trp. All had
mild skin fragility that had been initially
misdiagnosed or remained unrecog-
nized.
Diagnostic skin biopsies of the index
patients were subjected to indirect
immunofluorescence (IIF) staining using
a panel of antibodies to components of
the dermal–epidermal junction (Herz
et al., 2006), including the domain-
specific plectin antibodies: against the
rod domain, 5B3 (Foisner et al., 1994)
(a kind gift from Dr G Wiche, Vienna,
Austria) and 10F6 (Santa Cruz Biotech-
nology, Heidelberg, Germany),
and against the C-terminus, 31/Plectin
(directed against amino acids
3,062–3,184, BD Biosciences, Heidel-
berg, Germany) and GP21 (directed
against amino acids 4,367–4,684, Pro-
gen Biotechnik, Heidelberg, Germany).
The project was approved by the ethics
committee of the University of Freiburg.
For mutation analyses, EDTA–blood
was obtained from patients and family
members following written informed
consent in adherence to the Declara-
tion of Helsinki principles. The primers
for amplification of PLEC exons 31
and 32, and KRT5/KRT14, have been
described previously (McLean et al.,
1996; Arin et al., 2010), or designed
with primer 3.
The index patient of family A was
reported to be the only affected mem-
ber of the family (Figure 1a). He
had trauma-induced acral blisters and
erosions since the age of 3 years. With
increasing age, blistering diminished
and erosions predominated. Other
features encompassed posttraumatic
violaceous macules, hypopigmented
macules, especially evident on the
back, mild focal palmoplantar kerato-
derma, and pitting of the teeth (Figure
1b and c). IIF with the antibodies 5B3
and 10F6 indicated intraepidermal
microblisters and reduced staining
for plectin. PLEC mutation analysis
disclosed the heterozygous mutation
p.Arg2000Trp not only in the index
case but also in his father and two
siblings. Careful clinical examination
revealed mild skin fragility in all ofAbbreviations: EBS, epidermolysis bullosa simplex; IIF, indirect immunofluorescence; PLEC, plectin gene
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